LiveBitcoin Holds Near $84K as ETF Outflows Raise Rally Concerns: markets liveFollow the coverage →
Skip to content
Share
Market

IBRX Stock Has Shown Strength at Support, Will the Trend Reverse?

Follow The Market Periodical
IBRX Stock Has Shown Strength at Support, Will the Trend Reverse?
  • The ImmunityBio stock price jumped 25% after the company resubmitted the Cancer Therapy Application.
  • It has melted down by over 75% from the 52-week high.
  • The IBRX stock price has faced a good rejection from the $2.5 level.

ImmunityBio stock price has surged by over 25% in the previous trading session. It reacted to the news, that the company has resubmitted the application to the US FDA regarding the license of Bladder Cancer therapy. Earlier, the US FDA declined their application for the same. That news triggered the selling of the stock and it declined by over 55% in a single day on 11 MAY 2023.

The ImmunityBio stock price is currently in a downtrend and it has declined by over 75% from the 52-week high level. After, the fall the stock has gone sideways for 2 months between May and July. In July, the stock showed a breakdown from the $2.25 level and since then the stock price has been in a good downtrend. However, it seems like the stock price has formed a base at the level of $1.25.

The IBRX share price has formed a long wick on the upper side. It indicates that the stock has witnessed some profit booking at the end of the day. The stock has faced a rejection from the level of $2.25. This stock has retested the breakdown level and reversed. 

A Closer Look at the IBRX Stock Chart

The IBRX stock has surged heavily in the previous session signifies that some long position has been created in the stock. It has formed a double-bottom kind of pattern on the chart which is considered a bullish pattern. However, the stock has been declining and formed a Downward-sloping trendline and recently tested this trendline for the third time.

IBRX Stock Has Shown Strength at Support, Will the Trend Reverse?
Source: IBRX / NYSE By TradingView

It has jumped from the support level of $1.25 and it has directly gone to test the resistance level of $2.25. Now the other resistance level is present near to the $3.35 which is also looking strong as the price has fallen thrice from there. Considering the support level apart from $1.25, it is present near the level of $0.9368.

Synopsis of the Exponential Moving Average and Relative Strength Index

IBRX Stock Has Shown Strength at Support, Will the Trend Reverse?
Source: IBRX/ NYSE By TradingView

In the previous session, the IBRX stock price was able to close above the 50-day Exponential Moving Average. It can be the first sign of bullishness but it is still far below the 200-day Exponential Moving Average. Considering the Relative Strength Index, it is currently curving near 62 which signifies that the momentum is favouring Bulls.

Conclusion

The recent surge in the IBRX stock price has definitely boosted the confidence level of the buyers. They will surely reattempt to occupy the $2.25 level in the coming time. However, some selling pressure in the stock can bring the price down to the support level of $1.25.

Technical Level

Resistance – $2.25 and $3.35

Support – $1.25 and $0.9368

Disclaimer

The views and opinions stated by the author, or any people named in this article, are for informational purposes only. They do not establish financial, investment, or other advice. Investing in or trading crypto assets comes with a risk of financial loss.

D
Written by

Dr. Naveen Singh is an entrepreneur with achievements in sports, academics, healthcare, innovation, blockchain technology, telecommunications, and philanthropy. He is the Co-Founder and Chief Executive Officer (CEO) of Inery, the first layer-1 blockchain programmed for database management. With Inery, he aligns with his vision of a new paradigm for data to empower web3 and complete decentralization.

CryptocurrencyNewsBlog

About this article

PublishedOctober 27, 2023 4:35 pm
Last updatedJanuary 17, 2025 10:32 am
ReviewedFact-checked by the TMP editorial desk

This report follows our Editorial Policy, Fact-Checking Standards and Code of Ethics. Found an inaccuracy? See Corrections.

Disclaimer. Informational only, not financial advice. Crypto, forex and stocks are volatile, high-risk assets — always do your own research and consult a qualified adviser.

More in Market

Advertisement Your banner here — reach 400K+ crypto, forex & stock investors Advertise → 728 × 90